Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Estes

Showing results (261-270 of 286) with videos related to

Pageof 29
Sort By:
Nature|January 24, 2020
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8<sup>+</sup> cellsJulia Bergild McBrien, Maud Mavigner, Lavinia Franchitti, et al.
Nature Medicine|April 15, 2020
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruptionJustin Harper, Shari Gordon, Chi Ngai Chan, et al.
Plos Pathogens|August 22, 2024
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistenceBenjamin Varco-Merth, Morgan Chaunzwa, Derick M Duell, et al.
Nature|February 5, 2020
Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8<sup>+</sup> cellsJulia Bergild McBrien, Maud Mavigner, Lavinia Franchitti, et al.
Immunity|April 21, 2022
Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironmentsSizun Jiang, Chi Ngai Chan, Xavier Rovira-Clavé, et al.
Plos Pathogens|September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challengeKier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Science Immunology|June 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccineScott G Hansen, Meaghan H Hancock, Daniel Malouli, et al.
Nature Microbiology|January 30, 2026
Initial sites of SIV rebound after antiretroviral treatment cessation in rhesus macaquesBrandon F Keele, Afam A Okoye, Taina T Immonen, et al.
Nature Immunology|January 17, 2025
Author Correction: Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruptionSusan Pereira Ribeiro, Zachary Strongin, Hugo Soudeyns, et al.
Nature Immunology|September 12, 2024
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruptionSusan Pereira Ribeiro, Zachary Strongin, Hugo Soudeyns, et al.
Pageof 29

Showing results (261-270 of 286) with videos related to

Sort By:
Pageof 29
Nature|January 24, 2020
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8<sup>+</sup> cellsJulia Bergild McBrien, Maud Mavigner, Lavinia Franchitti, et al.
Nature Medicine|April 15, 2020
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruptionJustin Harper, Shari Gordon, Chi Ngai Chan, et al.
Plos Pathogens|August 22, 2024
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistenceBenjamin Varco-Merth, Morgan Chaunzwa, Derick M Duell, et al.
Nature|February 5, 2020
Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8<sup>+</sup> cellsJulia Bergild McBrien, Maud Mavigner, Lavinia Franchitti, et al.
Immunity|April 21, 2022
Combined protein and nucleic acid imaging reveals virus-dependent B cell and macrophage immunosuppression of tissue microenvironmentsSizun Jiang, Chi Ngai Chan, Xavier Rovira-Clavé, et al.
Plos Pathogens|September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challengeKier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Science Immunology|June 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccineScott G Hansen, Meaghan H Hancock, Daniel Malouli, et al.
Nature Microbiology|January 30, 2026
Initial sites of SIV rebound after antiretroviral treatment cessation in rhesus macaquesBrandon F Keele, Afam A Okoye, Taina T Immonen, et al.
Nature Immunology|January 17, 2025
Author Correction: Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruptionSusan Pereira Ribeiro, Zachary Strongin, Hugo Soudeyns, et al.
Nature Immunology|September 12, 2024
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruptionSusan Pereira Ribeiro, Zachary Strongin, Hugo Soudeyns, et al.
Pageof 29